Specific serologic response to genital human papillomavirus types in patients with vulvar precancerous and cancerous lesions

被引:10
作者
Heim, K
Widschwendter, A
Szedenik, H
Geier, A
Christensen, ND
Bergant, A
Concin, N
Höpfl, R
机构
[1] Innsbruck Med Univ, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria
[2] Innsbruck Med Univ, Dept Dermatol & Venerol, A-6020 Innsbruck, Austria
[3] Penn State Univ, Milton S Hershey Med Ctr, Dept Pathol, Jake Gittlen Canc Res Inst, Hershey, PA 17033 USA
关键词
antibody; human papillomavirus; vulvar cancer; virus-like particle; capsids; vulvar intraepithelial neoplasia; lichen sclerosus; squamous hyperplasia;
D O I
10.1016/j.ajog.2004.09.130
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: Antibodies to human papillomavirus are indicative for previous human papillomavirus exposure. Human papillomavirus antibody reactivities to vulvar precancerous lesions were reported poorly, and the role of human papillomavirus in some of these lesions is still unclear. Study design: In a direct enzyme-linked immunosorbent assay, serum samples from 126 healthy control subjects, 97 women with lichen sclerosus with or without squamous hyperplasia, 78 women with vulvar intraepithelial neoplasia, and 16 women with verrucous carcinoma were examined for immunoglobulin G and A antibodies to L1 virus-like particles of genital human papillomavirus types 6, 11, 16, 18, and 31, cutaneous human papillomavirus type 8, bovine papilloma virus, and cottontail rabbit papilloma virus. Results: In lichen sclerosus/squamous hyperplasia with atypia immunoglobulin G and A, antibody positivity rates to high-risk human papillomavirus virus-like particle types 16, 18, and 31 were significantly higher than in the control group and the lichen sclerosus/squamous hyperplasia group without atypia. In patients with vulvar intraepithelial neoplasia 1, increased immunoglobulin G antibody prevalences with both high-risk and low-risk human papillomavirus-virus-like particles were detected; whereas in patients with vulvar intraepithelial neoplasia II/III, this was observed only with the human papillomavirus types 16, 18, and 31. When only reactivities with 2 genital human papillomavirus types were compared, percentages of positives to only 1 of these 2 types ranged between 43% and 82%, with regard to all respective positives. Conclusion: Out, data support the role of high-risk human papillomavirus types, mainly human papillomavirus-16, in the pathogenesis of different vulvar lesions with atypia. Serologically, there are no indications that lichen sclerosus/squamous hyperplasia without atypia is associated with human papillomavirus, but high-risk human papillomavirus in lichen sclerosus/squamous hyperplasia with atypia could play a role in carcinogenesis. High antibody specificity was clearly demonstrated among 5 genital, 1 cutaneous human, and 2 animal papillomavirus types. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:1073 / 1083
页数:11
相关论文
共 28 条
[1]  
Carter JJ, 2001, CANCER RES, V61, P1934
[2]   HUMAN PAPILLOMAVIRUS TYPE-6 AND TYPE-11 HAVE ANTIGENICALLY DISTINCT STRONGLY IMMUNOGENIC CONFORMATIONALLY DEPENDENT NEUTRALIZING EPITOPES [J].
CHRISTENSEN, ND ;
KIRNBAUER, R ;
SCHILLER, JT ;
GHIM, SJ ;
SCHLEGEL, R ;
JENSON, AB ;
KREIDER, JW .
VIROLOGY, 1994, 205 (01) :329-335
[3]  
Chua KL, 1996, INT J CANCER, V68, P54, DOI 10.1002/(SICI)1097-0215(19960927)68:1<54::AID-IJC11>3.0.CO
[4]  
2-6
[5]   Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer [J].
Combita, AL ;
Bravo, MM ;
Touzé, A ;
Orozco, O ;
Coursaget, P .
INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (06) :796-803
[6]  
Crum CP, 1997, CURR OPIN OBSTET GYN, V9, P63
[7]   The serological response to papillomaviruses [J].
Dillner, J .
SEMINARS IN CANCER BIOLOGY, 1999, 9 (06) :423-430
[8]   Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer [J].
Heim, K ;
Widschwendter, A ;
Pirschner, G ;
Wieland, U ;
Awerkiew, S ;
Christensen, ND ;
Bergant, A ;
Marth, C ;
Höpfl, R .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (04) :705-711
[9]   SERUM IGG, IGM, AND IGA REACTIVITY TO HUMAN PAPILLOMAVIRUS TYPE-11 AND TYPE-6 VIRUS-LIKE PARTICLES IN DIFFERENT GYNECOLOGIC PATIENT GROUPS [J].
HEIM, K ;
CHRISTENSEN, ND ;
HOEPFL, R ;
WARTUSCH, B ;
PINZGER, G ;
ZEIMET, A ;
BAUMGARTNER, P ;
KREIDER, JW ;
DAPUNT, O .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (02) :395-402
[10]   Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: Results from a seroepidemiological case-control study [J].
Hildesheim, A ;
Han, CL ;
Brinton, LA ;
Kurman, RJ ;
Schiller, JT .
OBSTETRICS AND GYNECOLOGY, 1997, 90 (05) :748-754